Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212).

Arndt StahlerBeeke HoppeIl-Kang Na Luisa Keilholz Lothar MüllerMeinolf KarthausStefan FruehaufUllrich GraevenLudwig Fischer von WeikersthalEray GoekkurtStefan KasperAndreas Jay Kind Annika Kurreck Annabel Helga Sophie AligSwantje HeldAnke C Reinacher-Schick Volker HeinemannDavid HorstArmin JaroschSebastian StinzingTanja TrarbachDominik Paul Modest

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

wild-type mCRC. In PanaMa, Pmab + FU/FA maintenance was associated with beneficial outcomes in CMS2/4, whereas no benefit was observed in CMS1/3 tumors.

Keyphrases

wild type
metastatic colorectal cancer
clinical practice
stem cells
type diabetes
bone marrow
single molecule
weight loss
mesenchymal stem cells
cell therapy